effect overlay
activetrials
Dementia
Dementia
AusCADASIL

An Australian Cohort of CADASIL

HREC: 2023.213
Principal Investigator: Prof Amy Brodtmann
Coordinator contact: Dr Ashley Park
Funding: Non-Commercial
Stroke
Stroke
REVIVE

A phase 2b, multinational, randomized, double-blind study to investigate the efficacy and safety of redasemtide (S-005151) compared with placebo in adult participants with acute ischemic stroke who are not eligible for tissue plasminogen activator or thrombectomy

HREC: 2023.197
Principal Investigator: Prof Bruce Campbell
Coordinator contact: Christine Shin
Funding: Commercial
Stroke
Stroke
EXTEND-AGNES TNK

Post-thrombectomy intra-arterial tenecteplase for Acute manaGement of Non-retrievable thrombus and no-reflow in Emergent Stroke

HREC: 2023.138
Principal Investigator: Prof Bruce Campbell
Coordinator contact: David Jackson
Funding: Non-Commercial
Multiple sclerosis
Multiple Sclerosis
PRIMeS

Early detection and prevention of progressive disability in multiple sclerosis

HREC: 2023.123
Principal Investigator: Prof Tomas Kalincik
Coordinator contact:
Funding: Non-Commercial
Multiple sclerosis
Multiple Sclerosis
Outpatient Model of Care in Neuroimmunology

Human Centred Designed Model of Care in Neuroimmunology

HREC: 2023.035
Principal Investigator: Prof Tomas Kalincik
Coordinator contact: Katherine Fazzolari
Funding: Commercial